LCI Vaults On Bright Outlook, OSUR Gets Zika Contract, CLVS To Face FDA In Feb.

Shares of Lannett Co. Inc. (LCI) were up more than 14% in extended trading on Tuesday, following better-than expected Q4 results and bright outlook for fiscal 2017.

from RTT - Biotech http://ift.tt/2bU8zuB
via IFTTT